.png)
.png)
Assistant Professor
Beth Israel Deaconess Medical Center
Boston, MA, United States
Dr. Ruvandhi Nathavitharana is an Assistant Professor at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School. Dr. Nathavitharana’s research on tuberculosis (TB) is funded primarily by the US National Institutes of Health and focuses on the use of implementation science to optimize TB diagnosis and improve TB care delivery in high TB incidence countries, with a focus on Peru and South Africa. Dr. Nathavitharana has served as a technical expert analyzing data to inform WHO guideline development group panel recommendations on the accuracy of line probe assays for the diagnosis of TB and the impact of the urine lipoarabinomannan test.
Dr. Nathavitharana’s clinical efforts focus on the longitudinal, multidisciplinary care of patients with TB and non-tuberculous mycobacterial (NTM) infections. Dr. Nathavitharana is the Co-Director of the Social Justice Pathway for the BIDMC Internal Medicine Residency. Dr. Nathavitharana also serves the Chair of TB Proof, an advocacy organization, based in South Africa, whose mission seeks to combine stories and science to destigmatize TB and mobilize national and global resources to end TB.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Friday, October 21, 2022
10:30 AM – 11:45 AM US ET
Friday, October 21, 2022
11:20 AM – 11:45 AM US ET
Saturday, October 22, 2022
8:00 AM – 9:00 AM US ET
Saturday, October 22, 2022
8:00 AM – 8:30 AM US ET